Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00658112 · ClinicalTrials.gov registry record · Phase 4

Measuring Adherence in Subjects With Acne Vulgaris in a Clinic Population Subtitle: Topical Benzoyl Peroxide for Acne

A Phase 4 study, sponsored by Wake Forest University.

Completed
Registry status
Phase 4
Development phase
20
Enrollment target

NCT00658112 is a Phase 4 study that has completed, run by Wake Forest University. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00658112, a Phase 4 study, has completed, sponsored by Wake Forest University.

COMPLETED
Registry status
Phase 4
Development phase
20 participants
Enrollment target

Study Summary

The purpose of this research study is to see how often benzoyl peroxide is applied for acne. Use of medication was monitored electronically.

Interventions

  • DRUG Benzoyl Peroxide

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2006-07
Est. Completion 2008-05
Phase Phase 4

Sponsor

Wake Forest University

100 total trials

What the Registry Record Tells You About NCT00658112

The ClinicalTrials.gov registry entry for NCT00658112 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Benzoyl Peroxide is the first listed.

NCT00658112 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00658112 about?

NCT00658112 is a clinical study titled "Measuring Adherence in Subjects With Acne Vulgaris in a Clinic Population Subtitle: Topical Benzoyl Peroxide for Acne". The purpose of this research study is to see how often benzoyl peroxide is applied for acne. Use of medication was monitored electronically.

What is the current status of trial NCT00658112?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2006-07. Estimated completion is 2008-05.

What interventions are being tested in trial NCT00658112?

The interventions under investigation include: Benzoyl Peroxide (DRUG).

Who is sponsoring clinical trial NCT00658112?

This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.